{"product_id":"angiodynamics-marketing-mix","title":"AngioDynamics Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how AngioDynamics leverages its product innovation, pricing strategies, distribution channels, and promotional efforts to capture the medical device market. This glimpse into their 4Ps only hints at the strategic depth. \u003c\/p\u003e\n\u003cp\u003eUnlock the full picture of AngioDynamics' marketing success by exploring their product portfolio, pricing architecture, place in the market, and promotional campaigns. Get immediate access to a comprehensive, editable analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMinimally Invasive Medical Devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' product strategy centers on minimally invasive medical devices, targeting key medical fields like peripheral vascular disease and oncology. These devices are engineered to enhance patient recovery and facilitate complex medical interventions, reflecting a dedication to advancing healthcare through innovation. For instance, their commitment to oncology is evident in solutions for tumor ablation, a rapidly growing segment expected to reach approximately $12.5 billion globally by 2027, showcasing the market demand for such specialized products.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore  Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' core product platforms are the engine of its MedTech segment, with the Auryon Peripheral Atherectomy System, Mechanical Thrombectomy (AngioVac and AlphaVac), and NanoKnife Irreversible Electroporation leading the charge. These innovative solutions are designed to address critical needs in vascular interventions and oncology. \u003c\/p\u003e\n\u003cp\u003eFor the fiscal year ending April 30, 2024, AngioDynamics reported total revenue of $377.4 million, with its MedTech segment showing robust performance. The company's strategic focus on these core platforms is clearly paying off, contributing significantly to this growth and solidifying its market position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOncology Treatment Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' product strategy in oncology centers on innovative technologies like the NanoKnife System. This system, which received U.S. FDA 510(k) clearance for prostate tissue ablation in December 2024, represents a significant advancement in minimally invasive cancer treatment.  It offers physicians an alternative to traditional therapies, aiming to improve patient outcomes and quality of life.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVascular Disease Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAngioDynamics' vascular disease management offerings are central to treating peripheral vascular disease, with a product suite supporting procedures such as angioplasty, thrombolysis, and embolization.  This segment is crucial for addressing conditions that impact blood flow, particularly in the limbs.\u003c\/p\u003e\n\u003cp\u003eThe company's commitment to innovation is evident in the Auryon Atherectomy System. This device is currently under investigation in clinical trials, including the AMBITION BTK study, which focuses on critical limb ischemia.  Such trials are vital for validating new technologies and expanding treatment options.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct Focus:\u003c\/strong\u003e Peripheral vascular disease management through devices for angioplasty, thrombolysis, and embolization.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKey Innovation:\u003c\/strong\u003e Auryon Atherectomy System, evaluated for critical limb ischemia in trials like AMBITION BTK.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Relevance:\u003c\/strong\u003e Addresses a significant unmet need in treating conditions affecting limb blood flow.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Portfolio Optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAngioDynamics' strategic portfolio optimization, a key element of its Product strategy, involves a deliberate focus on high-growth Med Tech markets. This has been achieved through significant divestitures, including the sale of its Dialysis and BioSentry businesses in June 2023 and its PICC and Midline product portfolios in February 2024. These actions are designed to reallocate capital and management attention to areas with greater potential for profitability and expansion.\u003c\/p\u003e\n\u003cp\u003eThis portfolio streamlining is projected to enhance AngioDynamics' overall financial performance. By shedding lower-margin or non-strategic assets, the company aims to improve its top-line growth and bottom-line profitability in the coming fiscal years. For instance, the divestiture of the PICC and Midline portfolios, which represented a portion of their vascular access segment, allows for a deeper investment in their more advanced medical technology offerings.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eDivestiture of Dialysis and BioSentry:\u003c\/strong\u003e Completed in June 2023, this move signals a shift away from certain established, but perhaps less dynamic, product lines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSale of PICC and Midline Portfolios:\u003c\/strong\u003e Executed in February 2024, this further refines the company's focus within the vascular access market, prioritizing innovation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResource Reallocation:\u003c\/strong\u003e Proceeds and management focus from these divestitures are being directed towards higher-growth, higher-margin Med Tech segments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Focus:\u003c\/strong\u003e The objective is to strengthen AngioDynamics' position in markets offering greater long-term value and competitive advantage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Focus: Driving MedTech Innovation and Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' product strategy is a focused approach on high-growth MedTech segments, particularly in peripheral vascular disease and oncology. The company has strategically divested non-core assets, such as its Dialysis and BioSentry businesses in June 2023 and its PICC and Midline portfolios in February 2024, to concentrate resources on innovative platforms like the Auryon Atherectomy System and the NanoKnife Irreversible Electroporation system. This streamlining aims to bolster profitability and market leadership in advanced medical technologies.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct Platform\u003c\/th\u003e\n\u003cth\u003eKey Application Area\u003c\/th\u003e\n\u003cth\u003eFiscal Year 2024 Revenue Contribution (Millions USD)\u003c\/th\u003e\n\u003cth\u003eStrategic Significance\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuryon Peripheral Atherectomy System\u003c\/td\u003e\n\u003ctd\u003ePeripheral Vascular Disease\u003c\/td\u003e\n\u003ctd\u003e[Data not publicly available for specific product line revenue]\u003c\/td\u003e\n\u003ctd\u003eAddresses critical limb ischemia, undergoing clinical validation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNanoKnife Irreversible Electroporation\u003c\/td\u003e\n\u003ctd\u003eOncology (e.g., prostate tissue ablation)\u003c\/td\u003e\n\u003ctd\u003e[Data not publicly available for specific product line revenue]\u003c\/td\u003e\n\u003ctd\u003eMinimally invasive cancer treatment, FDA cleared for prostate.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAngioVac \/ AlphaVac\u003c\/td\u003e\n\u003ctd\u003eMechanical Thrombectomy\u003c\/td\u003e\n\u003ctd\u003e[Data not publicly available for specific product line revenue]\u003c\/td\u003e\n\u003ctd\u003eTreats venous and arterial thrombus, enhancing patient recovery.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThis analysis provides a comprehensive examination of AngioDynamics' Product, Price, Place, and Promotion strategies, offering actionable insights for marketing professionals.\u003c\/p\u003e\n\u003cp\u003eIt delves into AngioDynamics' marketing positioning by exploring its actual brand practices and competitive context, making it a valuable resource for strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clear, actionable framework for addressing market challenges, helping AngioDynamics streamline its product, price, place, and promotion strategies to alleviate customer pain points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' global distribution network is a cornerstone of its market strategy, ensuring its advanced medical technologies are accessible to healthcare providers across the globe. The company leverages a multi-channel approach, combining direct sales forces in key regions with a robust network of third-party distributors. This allows AngioDynamics to effectively penetrate diverse markets and cater to varying healthcare system structures.\u003c\/p\u003e\n\u003cp\u003eIn fiscal year 2023, AngioDynamics reported international net sales of $79.6 million, representing approximately 28% of its total net sales. This demonstrates a significant reliance on and success within its global distribution channels to drive revenue and expand market reach for its minimally invasive treatment solutions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTargeted Healthcare Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' distribution strategy for its medical devices, particularly those for minimally invasive procedures, centers on reaching the key medical professionals who use them. This means their sales efforts are directed towards interventional radiologists, vascular surgeons, and other specialists within hospital networks and outpatient clinics.\u003c\/p\u003e\n\u003cp\u003eThis targeted approach ensures that AngioDynamics' advanced products, such as their vascular access and interventional oncology devices, are placed directly with the trained physicians who perform the procedures. For instance, in fiscal year 2024, AngioDynamics reported a significant portion of its revenue derived from sales within hospital settings, underscoring the importance of this channel.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Partnerships for Market Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAngioDynamics actively pursues strategic partnerships to broaden its market access, particularly in international territories. These alliances are crucial for overcoming geographical barriers and ensuring their innovative medical devices reach a wider audience of healthcare professionals.\u003c\/p\u003e\n\u003cp\u003eBy collaborating with established local distributors, AngioDynamics enhances product availability and responsiveness. This strategy allows them to effectively meet the demand for their minimally invasive technologies, ensuring timely access for patients and clinicians in diverse healthcare settings. For instance, in 2023, AngioDynamics reported international sales contributing significantly to their overall revenue, highlighting the impact of such market-access strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEfficient Supply Chain and Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAngioDynamics places a strong emphasis on an efficient supply chain to ensure its medical devices reach healthcare providers promptly. This focus is vital for supporting critical patient care operations, particularly with high-value technologies where downtime is unacceptable.  For instance, in fiscal year 2023, the company reported improved inventory turnover, reflecting better management of its product flow.\u003c\/p\u003e\n\u003cp\u003eThe company's logistics strategy aims to minimize lead times and maintain consistent availability of its specialized products. This proactive approach is essential for building trust and reliability within the healthcare sector. AngioDynamics' commitment to supply chain excellence directly impacts its ability to serve its customer base effectively.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eTimely Delivery:\u003c\/strong\u003e Ensures critical medical devices are available when needed by healthcare facilities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInventory Management:\u003c\/strong\u003e Optimizes stock levels to balance availability with holding costs, aiming for efficiency gains seen in FY23.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLogistics Support:\u003c\/strong\u003e Facilitates the smooth distribution of complex medical technologies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHealthcare Operations:\u003c\/strong\u003e Underpins the seamless functioning of hospitals and clinics relying on AngioDynamics' products.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional and International Presence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAngioDynamics extends its reach beyond the United States, establishing a significant international footprint. This global network includes key operational hubs and sales offices strategically located in Amsterdam, Hong Kong, and Hamburg, Germany. Furthermore, a dedicated manufacturing facility in the United Kingdom underpins their commitment to worldwide distribution and localized market responsiveness.\u003c\/p\u003e\n\u003cp\u003eThis international presence is crucial for AngioDynamics' marketing strategy, enabling them to tailor product offerings and support to diverse regional demands. By operating in these key global markets, the company can better understand and adapt to varying regulatory landscapes and healthcare practices, thereby enhancing their competitive edge.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Distribution Network:\u003c\/strong\u003e Facilitates efficient product delivery to international markets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegional Market Responsiveness:\u003c\/strong\u003e Allows for adaptation to local healthcare needs and regulations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic International Locations:\u003c\/strong\u003e Amsterdam, Hong Kong, and Hamburg serve as vital operational centers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUK Manufacturing:\u003c\/strong\u003e Supports global supply chain and production capabilities.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Reach: Expanding Medical Technology Distribution Worldwide\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAngioDynamics' place strategy focuses on ensuring its advanced medical technologies are readily available to healthcare professionals worldwide. This involves a multi-channel distribution approach, utilizing both direct sales teams and a network of third-party distributors to penetrate diverse markets effectively.\u003c\/p\u003e\n\u003cp\u003eThe company's international sales highlight the success of its global distribution, with international net sales reaching $79.6 million in fiscal year 2023, representing about 28% of total net sales. This demonstrates a strong reliance on and effectiveness of its global channels in driving revenue and expanding market reach.\u003c\/p\u003e\n\u003cp\u003eAngioDynamics strategically targets key medical professionals like interventional radiologists and vascular surgeons, placing products directly within hospital networks and outpatient clinics where these procedures are performed.\u003c\/p\u003e\n\u003cp\u003eTheir global footprint, with operational hubs in Amsterdam, Hong Kong, and Hamburg, alongside UK manufacturing, allows for tailored product offerings and support, enhancing competitiveness by adapting to local regulations and healthcare practices.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eFY 2023 Value\u003c\/th\u003e\n\u003cth\u003eFY 2024 Projection\/Trend\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational Net Sales\u003c\/td\u003e\n\u003ctd\u003e$79.6 million\u003c\/td\u003e\n\u003ctd\u003eContinued growth expected, driven by expanded distribution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePercentage of Total Net Sales (International)\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003ctd\u003eTargeting increased international market share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKey International Hubs\u003c\/td\u003e\n\u003ctd\u003eAmsterdam, Hong Kong, Hamburg\u003c\/td\u003e\n\u003ctd\u003eOngoing investment in strategic locations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUK Manufacturing Facility\u003c\/td\u003e\n\u003ctd\u003eOperational\u003c\/td\u003e\n\u003ctd\u003eSupports global supply chain efficiency\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You Preview Is What You Download\u003c\/span\u003e\u003cbr\u003eAngioDynamics 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual document you’ll receive instantly after purchase—no surprises. This comprehensive analysis of AngioDynamics' 4 P's marketing mix is fully complete and ready for your immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55612256158073,"sku":"angiodynamics-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/angiodynamics-marketing-mix.png?v=1754768746","url":"https:\/\/growthsharematrix.com\/products\/angiodynamics-marketing-mix","provider":"Growth Share Matrix","version":"1.0","type":"link"}